Samsara BioCapital, LLC - VTV THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$781,773
-35.4%
1,635,5090.0%0.24%
+12.7%
Q2 2023$1,209,950
-8.4%
1,635,5090.0%0.21%
-22.3%
Q1 2023$1,321,164
+21.9%
1,635,5090.0%0.27%
+17.2%
Q4 2022$1,084,015
-31.7%
1,635,5090.0%0.23%
-37.0%
Q3 2022$1,586,000
+29.3%
1,635,5090.0%0.37%
+13.1%
Q2 2022$1,227,000
+3.9%
1,635,5090.0%0.33%
+10.1%
Q1 2022$1,181,000
-27.4%
1,635,5090.0%0.30%
-6.0%
Q4 2021$1,627,0001,635,5090.32%
Other shareholders
VTV THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ExodusPoint Capital Management, LP 16,072$27,0000.00%
TWO SIGMA INVESTMENTS, LP 88,300$150,0000.00%
Advisor Group, Inc. 4,000$6,0000.00%
BANK OF AMERICA CORP /DE/ 129,145$220,0000.00%
WELLS FARGO & COMPANY/MN 437$1,0000.00%
NORTHERN TRUST CORP 12,210$21,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 225,794$382,0000.00%
DEUTSCHE BANK AG\ 9,261$15,0000.00%
MORGAN STANLEY 5,215$9,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders